The AI trade everyone owns sits at the visible layer, but the physical chokepoint powering the entire buildout belongs to a corner of the market almost no growth portfolio touches. One specialist firm thinks…
Tim Cook and Satya Nadella both run trillion-dollar empires with impressive numbers, but strip away the accounting noise and buyback tricks and only one of them is actually winning where it counts.
Robinhood CEO Vlad Tenev walked into the White House and the CFTC with a bold claim: tokenization is not a niche experiment but the next architecture of global finance. What he wants from regulators…
Jim Cramer called out analysts for piling into the same fintech names at the same time, and the recent carnage in SoFi, Klarna, and PayPal suggests he spotted something the buy ratings missed.
Three big bank names have taken three wildly different paths through 2026, and the gap between the winner and the loser comes down to a business model difference that most investors overlook when picking…
One large-cap drugmaker has quietly lapped its peers in 2026 without a single obesity drug in its lineup, while the companies chasing the hottest trend in pharma are fighting for second place and last.
Three industrial giants all chased the same AI power buildout in 2026, but the market rewarded them very differently, and the gap between winner and also-ran reveals exactly what investors are betting on next.
An economist is calling the current U.S. industrial expansion the largest in the nation's history, projecting staggering investment figures that dwarf anything seen in the steel and auto eras. But the data behind the…
Live Updates Webull Q2 Earnings Coverage Wrap-Up4:31pm ETThat wraps up our initial coverage of Webull’s Q2 results. Thank you for stopping by! Pattern Day Trader Rule Removal Is Already Supercharging Webull4:30pm ETWebull said the…
Tempus AI wrote a $1.5 billion check for a genomics company most investors had never heard of, and one blockbuster clinical trial announcement just changed everything about how that deal looks.
Tilray surged Wednesday alongside Canopy Growth and Aurora Cannabis, but one number from 2026 tells a very different story about why today's rally leaves the real problem untouched.
A top equity strategist is steering clients away from the S&P 500, and the reasoning goes deeper than simple valuation math. The real story is a balance-sheet wound that quietly healed while most investors…
AI infrastructure spending and ballooning federal deficits are colliding in the Treasury market, and the shockwave is now hitting Asian tech stocks hard. The question is whether this is a brief repricing or the…
A $100 million buyback authorization from United States Antimony landed just days after a badly missed quarter and a guidance cut that nearly halved the full-year outlook, raising a pointed question about whether management…
Nelson Peltz is circling Wendy's with a take-private consortium even as the burger chain logs its sixth straight quarter of falling sales and shutters hundreds of restaurants. Whether deal fever or a genuine turnaround…
